Nicotinic Treatment for Cognitive Dysfunction

E-ISSN： 2212-5299|1|4|423-431

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.4, 2002-08, pp. : 423-431

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 45-62

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Cognitive Impairment in Schizophrenia: Potential Value of Phosphodiesterase Inhibitors in Prefrontal Dysfunction

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3813-3828

Bentham Science Publishers

Access to resources Recommend Favorite

The quest for the treatment of cognitive impairment: α₇ nicotinic and α₅ GABA_A receptor modulators

By Romanelli Maria Novella Gualtieri Fulvio

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 11, 2007-11 ,pp. : 1365-1377

Informa Healthcare

Access to resources Recommend Favorite

Effects of nicotinic stimulation on cognitive performance

By Newhouse P.A. Potter A. Singh A.

Current Opinion in Pharmacology, Vol. 4, Iss. 1, 2004-02 ,pp. : 36-46

Elsevier

Access to resources Recommend Favorite